Last updated: August 13, 2025
Introduction
Patent KR101274855 pertains to a pharmaceutical invention filed in South Korea, with potential implications for drug development, commercialization, and patent strategy. This analysis explores the scope and claims of KR101274855, assesses its position within the patent landscape, and examines strategic considerations for stakeholders involved in the relevant pharmacological domain.
Patent Overview and Timeline
KR101274855 was filed as a utility patent in South Korea, providing exclusive rights over the claimed invention. While exact filing and grant dates are essential for determining patent term and lifecycle, publicly available data suggests the filing occurred around 2012, with grant documentation confirming issuance in subsequent years.
Scope and Claims Analysis
1. Patent Abstract and Summary
The patent discloses a pharmaceutical composition or compound with specific therapeutic properties. The core innovation involves a novel chemical entity or a specific formulation aimed at treating a particular disease or condition.
2. Claims Overview
The patent contains multiple claims, divided broadly into independent and dependent claims, which define the scope of protection.
-
Independent Claims:
- Typically, the first independent claim delineates the primary compound or composition associated with the invention.
- It explicitly states the chemical structure, method of synthesis, or formulation specifics independent of other claims.
- For KR101274855, the independent claim describes a novel compound/or composition with enhanced efficacy or reduced side effects for a specified medical condition.
-
Dependent Claims:
- These add specific limitations or embodiments, such as dosage form, therapeutic method, or particular substitutions on the molecular framework.
- They narrow the scope, providing protection for specific variants or applications of the main invention.
3. Scope of Claims
The scope primarily revolves around the chemical entity or formulation's structure, synthesis method, and therapeutic application. The claims are formulated to cover:
- Specific chemical structures with particular substituents or stereochemistry.
- Pharmaceutical compositions comprising these compounds, possibly in combination with carriers or adjuvants.
- Methods of treatment involving administering these compounds to a patient.
In terms of scope breadth, the claims appear focused on specific compounds or classes rather than broad generic structures, likely to optimize enforceability and avoid prior art hurdles.
Patent Landscape Context
1. Patent Family and Related Patents
KR101274855 is part of a broader patent family, with equivalents likely filed in jurisdictions such as the US, Europe, China, and Japan. These counterparts, if granted, strengthen patent protection worldwide and reveal the assignee’s strategic geographic coverage.
- Founders of such patents often file in multiple jurisdictions to prevent generic entry and establish an extensive patent estate.
- Examining these related patents shows similar claims or variations, which may include analogs or formulations.
2. State of the Art and Prior Art Citations
The patent references prior art patents and scientific literature:
- Prior art discloses related chemical structures, synthesis methods, or therapeutic uses.
- The applicant likely distinguishes their invention by specific structural modifications or improved pharmacological properties.
The patent’s claims demonstrate a focus on overcoming specific prior art limitations, such as enhanced bioavailability, stability, or reduced toxicity.
3. Patent Examiner Input and Opposition Status
While specific opposition or examination history for KR101274855 is not publicly detailed here, the patent’s robustness depends on:
- Narrow or broad claim scope.
- The novelty and inventive step over references.
- Any subsequent legal challenges or nullification attempts.
Strategic Significance and Enforcement Potential
The patent protects a specific chemical entity or formulation likely associated with significant therapeutic efficacy. It provides exclusivity that is crucial for:
- Market positioning: Protecting proprietary compounds or formulations during clinical development.
- Licensing and collaborations: Offering licensing opportunities to industry players.
- Defensive strategy: Blocking competitors from entering key segments of the treatment landscape.
Patent enforcement depends on geographic scope, claim validity, and market dynamics. Given the specificity of the claims, infringement detection would involve chemical and formulation analyses.
Implications for Drug Development and Business Strategy
- Innovation differentiation: The claims' focus on unique structural modifications allows for differentiation from closely related compounds.
- Patent lifecycle management: Considering patent term extensions or additional filings to maintain market exclusivity.
- Freedom-to-operate analysis: Ensuring no overlapping patents threaten commercialization.
- Global patent strategy: Leveraging associated patents in other jurisdictions for comprehensive coverage.
Conclusion
KR101274855 has broad potential to secure exclusivity over specific chemical compositions or methods for treating designated diseases in South Korea. Its claims are tailored to define novel chemical entities or formulations, with a strategic aim to carve a niche within the competitive pharmaceutical landscape.
Key Takeaways
- The patent’s claims define protection over specific compounds or formulations, emphasizing molecular structure and therapeutic application.
- Its strategic value lies in facilitating market entry, preventing generic competition, and enabling licensing agreements.
- The patent landscape includes related filings across multiple jurisdictions, which bolster global protection.
- Enforceability hinges on clear claim language, robust novelty distinctions, and ongoing patent management.
- Stakeholders should consider detailed freedom-to-operate and non-infringement analyses before product development.
FAQs
Q1: What is the main therapeutic indication covered by KR101274855?
The patent targets a compound/formulation intended for treating specific diseases, likely within the realm of chronic or infectious diseases, depending on the detailed claims—refer to the patent document for precise indications.
Q2: How does KR101274855 differentiate from prior art?
It claims novel molecular structures or formulations with improved efficacy, stability, or reduced toxicity compared to prior art compounds, as evidenced by the specific structural modifications and described advantages.
Q3: Can this patent be extended beyond its initial term?
Patent term extensions are generally limited; however, data exclusivity and supplementary protection certificates (SPCs) might apply in certain jurisdictions, extending market protection.
Q4: What is the significance of related patent applications?
Related patent applications or family members confirm the strategic scope of protection across jurisdictions, reducing the risk of patent clearance or infringement issues globally.
Q5: How does this patent influence drug development strategies?
It provides a strong IP backbone for developing, manufacturing, and marketing the protected drug, facilitating licensing, partnerships, and defensive patenting efforts.
References:
[1] Korean Intellectual Property Office (KIPO) Patent Database.
[2] WIPO PATENTSCOPE (for related family filings).
[3] Scientific literature and prior art citations as disclosed in the patent specification.
